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BY-NC-ND license (http://creativecomAbstract Objective: To investigate the percutaneous penetration effect of essential oil of
mint from Mentha haplocalyx Briq. on the complex active components in Chinese herbal
external preparations, and assess its toxicity on the skin cells.
Methods: The cytotoxicity of mint oil on HaCaT keratinocytes and CCC-ESF-1 fibroblasts was
measured using an MTT assay. Five model drugs with a wide range of lipophilicity, namely ost-
hole, tetramethylpyrazine, ferulic acid, puerarin, and geniposide, were tested using in vitro
permeation studies to investigate the percutaneous penetration enhancement effect of mint
oil. Secondary structure alterations of skin stratum corneum (SC) were measured using Fourier
transform infrared spectroscopy (FTIR). Saturation solubilities and SC/vehicle partition coeffi-
cients of the five model drugs with and without mint oil were also determined to understand
the potential mechanisms of the essential oil.
Results: Half maximal inhibitory concentration (IC50) values of mint oil were significantly high-
er in HaCaT and CCC-ESF-1 cell lines than values in the well-established and standard penetra-
tion enhancer Azone.
Conclusions: Mint oil at proper concentration could effectively facilitate percutaneous pene-
tration of both lipophilic and hydrophilic drugs, and exhibit higher efficiency for moderate hy-
drophilic drugs. Mechanisms of penetration enhancement by mint oil could be explained with8473 8603.
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Mint (Mentha haplocalyx Briq.) belongs to the labiatae
family and is widely used as a traditional Chinese medicine
(TCM) for its medicative properties and is also an important
ingredient in health care products and foods. The Chinese
classic Rhymed Discourse on Topical Remedies (Li Yue Pian
Wen; 1870) mentions herbs that are rich in essential oil,
such as mint, have unique properties that can facilitate
absorption through the skin of active components in a
topical herbal prescription. Thus, in addition to its thera-
peutic properties, the essential oil from mint is used
extensively in traditional Chinese external preparations for
its purported ability to promote absorption of other herbal
ingredients.
Despite some studies have reported the activity of
essential oil of mint as a transdermal penetration
enhancer,1,2 a single Chinese herbal ingredient or pharma-
ceutical component is commonly used to evaluate its
penetration enhancement activity, thus it is difficult to
fully assess its enhancement properties in multi-ingredient
external preparations. Due to the complexity of Chinese
herbal formulas, there is currently no systematic informa-
tion available about the skin permeation effect of mint oil
on the complex active components in Chinese external
preparations.
Although certain physicochemical parameters of drug
molecules are associated with their skin permeability,
including molecular size, lipophilicity, acidity or basicity,
among others, the quantitative structure-activity relation-
ship (QSAR) has revealed that drug lipophilicity is the pre-
dominant factor which affects the skin permeability of
drugs,3,4 and there is little correlation between the drug
molecular size and penetration rate within a narrow range
of molecular weight (200e500).5 Therefore, based on these
studies, the complex active components in Chinese herbal
external preparations can be roughly represented with
herbal components with a wide range of different
lipophilicities.
In this study, to investigate the penetration enhance-
ment effect of mint oil on the complex active components
in Chinese herbal external preparations, a series of TCM
model drugs with a wide range of lipophilicity represented
by n-octanol/water partition coefficient (logKo/w) were
selected, namely osthole (OT, logKo/w Z 3.85), tetrame-
thylpyrazine (TMP, logKo/wZ 2.34), ferulic acid (FA, logKo/
wZ 1.26), puerarin (PR, logKo/wZ 0.35), and geniposide
(GP, logKo/wZ 1.01). The physicochemical parameters of
these five model drugs are presented in Table 1. In addi-
tion, skin epidermal keratinocytes (HaCaT cells) and dermal
fibroblasts (CCC-ESF-1 cells) were employed to monitor the
cytotoxicity of mint oil.Materials and methods
Drugs and chemicals
Osthole (OT), puerarin (PR) and geniposide (GP) were pur-
chased from NCE Biomedical Co., Ltd. (Wuhan, China).
Ferulic acids (FA), laurocapram (Azone), and l-menthol were
supplied by Sinopharm Chemical reagent Co., Ltd. (Beijing,
China). Menthone was purchased from Tokyo Chemical In-
dustry Co., Ltd. (Shanghai, China). Tetramethylpyrazine
(TMP), propylene glycol (PG), polyoxyethylene (20) oleyl
ether (Brij-98), dimethyl sulfoxide (DMSO), C8eC20 n-alkanes
and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) were obtained from SigmaeAldrich
(Shanghai, China). Acetonitrile of HPLC grade was purchased
from Merck KGaA (Darmstadt, Germany). Acetic acid was
supplied by Beijing Chemical Reagent Co., Ltd. All other
chemicals used were of analytical grade.
Plant material and essential oil extraction
Aerial parts of Mint (Mentha haplocalyx Briq.) used in this
work were supplied by Ben Cao Fang Yuan Pharmaceutical
Co., Ltd (Beijing, China), and identified by Associate Pro-
fessor Peng Tan (Department of Chinese Pharmacy, Beijing
University of Chinese Medicine, Beijing, China). A voucher
specimen (#MH131007) was deposited in the Department of
Chinese Pharmacy, Beijing University of Chinese Medicine.
The dried herbs (2.0 kg) were subjected to hydro-
distillation in 12 volumes of water (v/w) for 2 hours by
using a Clevenger-type apparatus. The yellowish essential
oil was obtained in a yield of 0.95% (w/w) after drying with
anhydrous sodium sulphate and stored under N2 at 4
C in a
sealed brown vial until tested and analyzed.
Cell line and culture
HaCaT (epidermal keratinocytes) and CCC-ESF-1 (dermal fi-
broblasts) cell lines were supplied by the Cell Resource Cen-
ter, Institute of Basic Medical Sciences, Chinese Academy of
Medical Sciences (Peking Union Medical College, China). The
cells were grown in Minimum Essential Medium (MEM Eagles
with Earle’s Balanced Salts) and Dulbecco’s Modified Eagle’s
Medium (DME H-21 4.5 g/L glucose), supplemented with 10%
(v/v) fetal bovine serum (FBS), 100 units/ml penicillin/
streptomycin at 37C in a 5% CO2 incubator.
High performance liquid chromatography (HPLC)
methods for determination of the model drugs
The HPLC system for analyzing drug concentrations was
equipped with an SPD-20A variable-wavelength ultraviolet
Table 1 Physicochemical properties of model drugs.
Parameters Model drugs
Geniposide Puerarin Ferulic acid Tetramethylpyrazine Osthole
MWa (g/mol) 388.37 432.38 194.18 136.20 244.34
logKo/w
b at 32C 1.01 0.35 1.26 2.34 3.85
Melting pointc (C) 161e162 187e189 174 76e78 79.5e81.4
Solubility in water
at 32C (mg/mL)
481.87 3.64 0.54 4.72 1.32  103
pKac 12.80 6.46 4.58 3.20 e
a Molecular weight.
b N-octanol/water partition coefficient.
c Source Z SciFinder database.
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integrating system (Shimadzu Corporation, Kyoto, Japan).
Purospher STAR RP-18 (250 4.6 mm i.d., 5 mm particle size;
Merck KGaA) reversed-phase column was used to determine
the content of TMP, Alltima HP C18 AQ (250  4.6 mm i.d.,
5 mm particle size; W.R. Grace & Co.-Conn, Columbia, MD,
USA) column was utilized to measure the content of GP and
PR, and Lichrospher RP-18e (250X4.6 mm i.d., 5 mm particle
size; Merck KGaA) column was employed to analyze the
content of OT and FA. HPLC conditions were as follows: mo-
bile phase for OT was a mixture of acetonitrile and distilled
water (80:20, v/v), wavelength was set at 320 nm, and
retention time of OT was 5.8 minutes. Mobile phase for TMP
consisted of acetonitrile and distilled water (60:40, v/v),
wavelength was set at 282 nm, and retention time of TMP was
5.6 minutes. Mobile phase for FA consisted of acetonitrile and
1% acetic acid in distilled water (30:70, v/v), wavelength was
set at 323 nm, and retention time of FA was 5.9 minutes.
Mobile phase for PRwas amixture of acetonitrile and distilled
water (20:80, v/v), wavelength was set at 240 nm, and
retention time of PR was 5.5 minutes. Mobile phase for GP
consisted of acetonitrile and distilled water (20:80, v/v),
wavelength was set at 251 nm, and retention time of GP was
5.3 minutes. Flow rate under the above five conditions was
1.0 mL/min. Specificity, linearity, intra- and inter-day vari-
ability, and recovery of these methods were tested. Repro-
ducibility, calculated as RSD of successive injection of six
solutions carried out on 3 different days, was 0.34, 1.34, 0.24,
0.16, and 6.52% for OT, TMP, FA, PR and GP, respectively.Gas chromatographyemass spectral analysis
Mint oil was subjected to gas chromatographyemass spec-
trometry (GCeMS) analysis on a Shimadzu QP-2010 system
equipped with a NIST database and a Rxi-5Sil MS capillary
column (30 m  0.25 mm  0.25 mm, Restek Corporation,
Bellefonte, PA, USA). Helium (99.99%) was the carrier gas at
a flow rate of 1.0 mL/min. Oven temperature was pro-
grammed from 50C to 240C at a rate of 3 C/min. Injector
temperature, MS transfer line, and ion source temperatures
were set at 250C, 280C, and 250C, respectively. Mass
scanning was in the range of 35e500 amu. Split ratio was
1:50. An aliquot (1.0 mL) of the diluted samples (1/100 in
ethyl acetate, v/v) was injected automatically.The constituents of the essential oil were identified by
matching their mass spectral fragmentation patterns with
those in a NIST2008 mass spectra library and also by
comparing their Kovats retention indices, which were
determined by injection of the sample with a solution
containing the homologous series of C8eC20 n-alkanes as
reported previously.6 The major oil contributors were
further confirmed by comparing the corresponding pure
standard compounds. The percentage composition was
computed by the normalization method from the GC peak
areas.
Cytotoxicity
In vitro cellular toxicity of mint oil and associated en-
hancers was evaluated in dermal fibroblast and epidermal
keratinocyte cultures using a MTT assay. Fibroblasts or
keratinocytes were seeded into 96-well plates at a density
of 7000 cells in 100 ml medium per well. After 24 hours, the
cells were incubated with varying concentrations of
enhancer solution in a culture medium with 1% DMSO (as a
vehicle) for 24 hours at 37C. Cells that were treated with
culture medium containing 1% DMSO were used as control.
Subsequently, the medium was removed and supplemented
with fresh medium containing 20 mL MTT solution (5 mg/mL
in phosphate buffer) and the cells were incubated for
4 hours. The medium was then replaced with 150 ml DMSO
to dissolve the formazan crystals. The plate was incubated
for 10 minutes while shaking. Absorbance was read at
490 nm using a Multiskan microplate spectrophotometer
(Thermo Scientific, USA). The half maximal inhibitory con-
centrations (IC50) were calculated using SPSS software
v16.0 as previously described.7
Preparation of full thickness skin and stratum
corneum (SC)
Male SpragueeDawley rats (5 weeks of age, 200  10 g)
were purchased from Shibeifu Laboratory Animal Technol-
ogy Co., Ltd. (Beijing, China). All experiments were carried
out in accordance with the Guiding Principles for the Care
and Use of Laboratory Animals, Beijing University of Chi-
nese Medicine, China, and the experimental protocol was
approved by the Committee on Animal Research of Beijing
University of Chinese Medicine. After sacrificing the rats
112 J. Wang et al.with excess ether inhalation, hair from the abdominal sur-
face was shaved with caution so as not to injure the skin.
The shaved skin was then excised from the animals. The
subcutaneous tissue was removed surgically and the dermal
surface was wiped with a cotton swab to remove adhered
fat tissue. The full thickness skin was subsequently cleaned
with phosphate buffer saline.
The excised rat skin was treated with 0.4% trypsin in PBS
(pH 7.2) at room temperature for 10 hours. A cotton swab
moistened with distilled water was used to separate the
epidermis. SC sheets were thoroughly washed with water
and dried in a vacuum desiccator until tested.
Skin permeation studies
The modified Franz vertical diffusion cell system (Shanghai
KaiKai Technology Trade Co., Ltd., Shanghai, China) was
used, and each cell had a volume of 7 ml and an effective
area of 1.77 cm2. The epidermis prepared was sandwiched
between the diffusion cells with the stratum corneum side
up and the dermal side exposed to the receiver compart-
ment. The donor compartment was filled with the drug
solution (approx. 20 mg/mL) in propylene glycol:water
(PG:water Z 80:20). The receptor compartment was filled
with the PBS (pH 7.4) for TMP, FA, PR, and GP, and 3% (w/v).
Brij 98 in PBS was used as receiver solution for OT. The
temperature and the stirring rate were maintained at 32C
and 300 rpm, respectively. The skin was then treated with
2 mL of various concentrations of the corresponding pene-
tration enhancers. The control was treated with a vehicle
only. An aliquot (1 mL) of the sample was withdrawn from
the receptor chamber at a predetermined intervals (1, 2, 4,
6, 8, 10, 12, 22, and 24 hours), and replaced with the
equivalent volume of fresh solution. All samples were
analyzed by the means of the HPLC method previously
described for drug quantification.
Determination of saturation solubility of model
drugs
To investigate the effect of mint oil on the saturation sol-
ubility of the model drugs, excess drug was added to the
known volumes of the vehicle with or without varying
concentrations of mint oil, vortexed for 5 minutes followed
by sonication for 15 minutes to dissolve the drug and then
equilibrated at 32C for more than 24 hours. Finally, the
saturated solution was centrifuged at 10 000 rpm for
10 minutes and aliquots of supernatant were filtered
through 0.22 mm nylon filter and diluted by the corre-
sponding mobile phase before HPLC analysis.
Measurement of SC/vehicle partition coefficient of
model drugs
The partition coefficient of model drugs into stratum cor-
neum with or without various concentrations of mint oil
treatment was measured as reported previously.8 SC sam-
ples were pulverized using mortar and pestle. One milliliter
of varying concentrations of mint oil in propylene glycol:-
water (PG:water Z 80:20 v/v) containing 10% (w/v) of
model drug was added to 10 mg ground SC with frequentvortexing. The control was treated with a vehicle only. The
mixture was equilibrated for 12 hours at 32C. The super-
natant solution was obtained by centrifuging at 10,000 rpm
for 10 minutes and then analyzing for the drug content. The
amount of drug bound to the SC was calculated by sub-
tracting the amount of the drug in the supernatant from the
initial drug concentration. All partition studies were con-
ducted in triplicate. The partition coefficient (K ) of the
model drug was obtained using the following equation:
KZ drug concentration in SC/drug concentration in vehicle.
Calculation of physicochemical parameters of
model drugs
Five model drugs were chosen based on their lipophilicity
represented as logKo/w. The melting point and pKa values of
model drugs were obtained from the SciFinder database.
The solubility in water at 32C of model drugs was
measured with the method described above under Deter-
mination of saturation solubility of model drugs. The
logKo/w values were determined with reference to the
previously reported method.9
Fourier transform infrared spectroscopy (FTIR)
studies
The dried SC sheet was cut into approximately 1 cm2 pieces
and incubated for 12 hours in 5 mL of the respective solu-
tions at room temperature, where the solution was 1%, 3%,
5% mint oil, solvent (propylene glycol:WaterZ 80:20, used
as the control), respectively. Meanwhile, normal SC without
any treatment was used as the blank group. The SC was
then cleaned carefully with distilled water to remove the
residual solvent on the SC surface and placed in a vacuum
desiccator at 37C overnight for complete dehydration. The
spectral measurements of all pieces were made with a
NEXUS FTIR spectrometer (Thermo Nicolet, USA) equipped
with an attenuated total reflectance (ATR) attachment with
the following parameters: resolution of 2 cm1, scanning
times of 100, and scanning range of 650e4000 cm1. The
FTIR spectral curves in each group were recorded using
OMNIC 6.2 program attached to the IR instrument itself.
Data and statistical analysis
Parameters for the skin permeation studies were calculated
by plotting the cumulative amount of drug permeated
across the skin against time (h). Steady state flux (Js) was
calculated as the slope of the linear portion of the plot
(between 8 and 14 hours). Lag time (Tlag) was determined
by extrapolating the linear portion of the curve to the X-
axis. The cumulative drug amount in the receptor chamber
after 24 hours (Q24) and diffusion parameter (D/h
2) were
calculated using the following equations:
Q24ZVrCt þ
Xt1
iZ0
VsCi ð1Þ
D

h2Z1

6Tlag
 ð2Þ
Where Ci is the drug concentration of the receiver solution
at each sampling time, Ct is the drug concentration of the
Percutaneous penetration enhancement effect of mint oil 113sample in the receiver, Vs and Vr are the volumes of the
sampling solution and the receiver solution, respectively. D
is the diffusion coefficient within the skin, h is the diffu-
sional path length.
In order to compare the permeation enhancement ca-
pacity of different concentrations of mint oil, the
enhancement ratio (ER) for flux was calculated using the
following equation: ER Z flux for skin treated with essen-
tial oil/flux for control (exposed to only vehicle).
Data were expressed as the mean value  SD and the
number of replicates (n) was given in the pertinent figures.
A two-tailed Student’s t-test was used when comparing two
different conditions. In all cases, P < 0.05 was considered
significant.Table 2 Major components of the essential oil from mint detec
tR
a (min) Compounds
9.47 3-Octanol
10.89 Cineole
10.98 Limoene
13.67 Linalool
14.70 2-isopropylidenecyclohexanone
15.50 Isopulegol
15.65 Menthone
16.01 Isomenthone
16.32 Borneol
16.44 Isomenthol
16.54 Cryptone
16.94 Menthol
17.25 4-isopropyl-1-methylcyclohexanol
17.43 ɑ-terpineol
18.36 1-isopropenyl-2-methoxybenzene
19.21 Pulegone
19.73 Piperitone
21.92 Carvacrol
22.17 Menthyl acetate
23.32 Eucarvone
24.42 2-isopropylidenecyclohexanone
24.52 Terpinyl acetate
25.87 Jasmone
26.16 Cinerolone
26.50 b-bourbonene
26.78 b-Elemen
27.87 Caryophyllene
28.85 5,9-Tetradecadiyne
29.19 a-Caryophyllene
29.52 Bicyclosesquiphellandrene
30.26 Germacrene D
30.88 Elixene
31.93 Delta-cadinene
33.36 Nerolidol
33.63 Espatulenol
33.83 Caryophyllene oxide
35.20 Cubenol
36.06 T-cadinol
36.50 a-cadinol
Total
a tR is the retention time of the identified compounds.
b RI is Kovat retention indices on Rxi-5Sil MS column.
c It is further confirmed by using the corresponding pure compoundResults and discussion
Chemical compositions of mint oil
Principal compounds were identified from mint oil, ac-
counting for 92.84% of the total oil (Table 2). Two major oil
contributors (menthol and menthone, which represented
57.11% of the total oil) were further confirmed using the
corresponding pure compounds. Based on the results of
GCeMS analysis, mint oil contained high contents of
oxygenated monoterpenes, and the principal components
were menthol (51.00%), 2-isopropylidenecyclohexanone
(11.49%), menthone (6.11%), cinerolone (3.19%) and
eucarvone (2.58%). Generally, the biologic properties of theted by GCeMS.
RIb ID method Relative content (%)
978 MS, RI 0.36
1015 MS, RI 0.35
1018 MS, RI 0.32
1082 MS, RI 0.31
1106 MS, RI 0.23
1124 MS, RI 0.28
1127 MS, RIc 6.11
1135 MS, RI 1.99
1142 MS, RI 0.22
1145 MS, RI 1.19
1147 MS, RI 0.18
1156 MS, RIc 51.00
1163 MS, RI 0.12
1167 MS, RI 0.60
1188 MS, RI 0.57
1207 MS, RI 1.32
1219 MS, RI 2.19
1268 MS, RI 0.24
1274 MS, RI 0.62
1300 MS, RI 2.58
1325 MS, RI 11.49
1328 MS, RI 0.12
1359 MS, RI 0.93
1366 MS, RI 3.19
1374 MS, RI 0.19
1380 MS, RI 0.13
1406 MS, RI 1.80
1430 MS, RI 0.17
1439 MS, RI 0.20
1447 MS, RI 0.15
1465 MS, RI 1.36
1480 MS, RI 0.27
1506 MS, RI 0.16
1543 MS, RI 0.13
1550 MS, RI 0.57
1555 MS, RI 0.58
1591 MS, RI 0.14
1614 MS, RI 0.19
1626 MS, RI 0.29
92.84
. ID: identification.
114 J. Wang et al.essential oil depended directly on its principal components,
and some terpenes, such as menthol10 and menthone,11
from the essential oil could facilitate the transdermal
permeation of drugs, suggesting these major oil contribu-
tors play an important role in the enhancement activity of
mint oil as penetration enhancer.
Cytotoxicity of M. haplocalyx oil on skin cells
Although many penetration enhancers exhibit satisfactory
performance in facilitating transdermal permeation ab-
sorption of drug molecules, few have been used in clinical
application on account of their skin irritation or toxic
properties. Thus, the cytotoxicity on skin cells of mint oil
was measured with a MTT assay. The well-established and
standard penetration enhancer Azone was selected to
compare and better evaluate skin cytotoxicity of the
essential oil. The examined enhancers induced roughly
dose-dependent reductions in cellular viability (Fig. 1). The
IC50 values (namely the concentration of drugs inducing a
50% decrease in cell viability) of mint oil were significantly
higher in both HaCaT keratinocytes and CCC-ESF-1 fibro-
blasts in comparison to those of Azone (Table 3), indicating
that mint oil probably possesses low skin irritation
potential.
Effect of mint oil on percutaneous permeation of
model drugs
To investigate the permeation enhancement activity of
mint oil through rat skin, low, medium, and high concen-
trations (1%, 3%, and 5% v/v) of the oil were prepared by
dissolving corresponding content of the essential oil in a
mixture of PG: water (80:20, v/v). PG:water was selected
as a base solvent due to its ability to solubilize all tested
components, including OT, mint oil and Azone. Moreover,
considering the poor water solubility of OT, 3% (w/v) Brij 98
was added into the receiver fluid to improve its solubility,
resulting in the sink condition for the skin permeation
experiment of OT.12
The permeation profile and permeation parameters of
OT (flux, Tlag, Q24, and ER) through rat skin are presented inFigure 1 Toxicities of mint (M. haplocalyx) oil and Azone in H
expressed as mean  SD. These two space are 1/4 SBC case spaceFig. 2 and Table 4, respectively. Mint oil increased the
steady state flux and Q24 value of OT in a concentration-
dependent manner, and the Q24 value of 5% mint oil
(457.07  52.47 mg/cm2) was increased by 6.76-fold
compared with the control. Tlag value of the 10% oil group
was significantly higher than that of the control (P < 0.05),
while the other groups exhibited no obvious difference.
The effect of mint oil on the percutaneous profile and
permeation parameters of TMP (flux, Tlag, Q24, and ER)
through the rat skin are shown in Fig. 2 and Table 4,
respectively. All examined enhancers had promoting effect
on the percutaneous permeation of TMP (P < 0.05) in
comparison with the control. The steady state flux, Tlag,
and Q24 values of three different concentrations of oil
significantly increased with the increase in oil concentra-
tion. The 5% oil group exhibited (ERflux Z 15.14) better
effect on the percutaneous permeation of TMP compared
with the 1% oil group (ERflux Z 1.58) and 3% oil group
(ERflux Z 2.36).
The permeation profile and permeation parameters of
FA (flux, Tlag, Q24, and ER) through rat skin are displayed in
Fig. 2 and Table 5, respectively. A significant increase in Q24
value was observed by incorporation of 1% mint oil, while
the steady state flux and Tlag values exhibited no obvious
enhancement. The remaining two concentration (3%, 5%
mint oil) induced significant increase in flux, Tlag, and Q24
compared with the control (P < 0.05). Similar to TMP,
permeation enhancement activity of 5% mint oil
(ERflux Z 206.90) was higher than that of 1% oil
(ERflux Z 1.46) or 3% oil (ERflux Z 5.06).
Effect of mint oil on the percutaneous profile and
permeation parameters of PR (flux, Tlag, Q24, and ER)
through the rat skin are shown in Fig. 2 and Table 5,
respectively. 1% mint oil had no promoting effect on the
percutaneous permeation of PR (P > 0.05) compared with
the control, while significant increases in flux, Tlag, and Q24
were observed with the presence of 3% or 5% mint oil. 5%
mint oil provided the highest increase in steady state flux
(165.65  91.61 mg/cm2/h), with an ERflux of 3313.00-fold.
Permeation profile and permeation parameters of GP
(flux, Tlag, Q24, and ER) through rat skin are displayed in
Fig. 2 and Table 6, respectively. Apart from the 5% mint oil,
1% or 3% mint oil had no promoting effect on theaCaT keratinocyte and CCC-ESF-1 fibroblast cell lines. Values
.
Table 3 IC50 values of mint oil and Azone for HaCaT and
CCC-ESF-1 cell lines.
Enhancer IC50 (mg/mL)
a
HaCaT CCC-ESF-1
Azone 0.047  0.002 0.048  0.004
Mint oil 1.255  0.016b 2.461  0.074b
a Values expressed as mean  SD (n Z 6).
b P < 0.05.
Percutaneous penetration enhancement effect of mint oil 115percutaneous permeation of GP (P > 0.05) in comparison
with the control. The increase in steady state flux, Tlag, and
Q24 was observed with incorporation of 5% mint oil
(P < 0.05).
Based on the results of the skin penetration studies,
mint oil could enhance the percutaneous permeation ofFigure 2 Permeation profiles of five model drugs through excthose model drugs in a concentration-dependent manner,
and the Tlag values of all model drugs increased by incor-
poration of different concentrations of essential oil. Among
the three different concentration groups, 5% mint oil
exhibited significantly higher penetration enhancement
activity than the other two concentrations, suggesting that
better percutaneous enhancement effect in TCM external
preparations could be obtained when the concentration of
mint oil reached up to 5%. Although 1% mint oil exhibited
negligible enhancement in the percutaneous permeation of
those model drugs, except for TMP, compared with the
control, mint oil at proper concentration could effectively
facilitate percutaneous permeation of drugs with different
lipophilicity, including extremely lipophilic and hydrophilic
drugs.
According to the relationship between logKo/w of the
model drugs and their logERflux (Fig. 3), it was found that
the relationship tended to exhibit as a parabolic curve, andised rat skin. Values are expressed as mean þ SD (n Z 5).
Table 4 Percutaneous permeation parameters of OT and TMP through excised rat skin.
Enhancer OT TMP
Solubility
(mg/mL)
Flux
(mg/cm2/h)
Tlag (h) Q24 (mg/cm
2) ERFlux
(logER)
a
Solubility
(mg/mL)
Flux (mg/cm2/h) Tlag (h) Q24 (mg/cm
2) ERFlux (logER)
a
Control 9.14  0.36 1.68  0.14 2.79  0.61 67.58  7.22 e 268.97  0.92 20.10  2.36 2.10  0.39 929.89  84.00 e
1% mint oil 12.15  0.39b 2.20  0.49 3.13  0.51 88.02  15.19b 1.31 (0.12) 278.61  4.98 31.66  6.29b 2.69  0.34b 1561.44  307.12b 1.58 (0.20)
3% mint oil 14.42  1.25b 3.35  0.15b 2.94  0.97 177.24  27.65b 1.99 (0.30) 290.76  5.99b 47.36  8.62b 3.08  0.18b 2163.20  329.74b 2.36 (0.37)
5% mint oil 14.01  0.98b 13.49  2.60b 4.31  0.63b 457.07  52.47b 8.03 (0.90) 291.68  3.09b 304.32  88.99b 5.28  0.23b 16582.82  1206.94b 15.14 (1.18)
a ERFlux is the enhancement ratio calculated as follows: ERZ flux (with enhancer)/flux (without enhancer); logER is the natural logarithm
value of the corresponding ERFlux.
b Each value is expressed as mean  SD (n Z 5), except for ERFlux.
Table 5 Percutaneous permeation parameters of FA and PR through excised rat skin.
Enhancer FA PR
Solubility
(mg/mL)
Flux
(mg/cm2/h)
Tlag(h) Q24 (mg/cm
2) ERFlux
(logER)
a
Solubility
(mg/mL)
Flux
(mg/cm2/h)
Tlag(h) Q24 (mg/cm
2) ERFlux
(logER)
a
Control 53.51  0.16 1.63  1.10 2.61  1.09 71.02  44.80 e 126.60  0.52 0.05  0.04 2.59  0.61 2.19  1.86 e
1% M.haplocalyx oil 61.06  0.89b 2.38  1.73 2.66  0.93 125.95  91.77b 1.46
(0.16)
131.37  1.84b 0.03  0.02 2.97  0.87 2.79  1.36 0.60
(0.22)
3% M.haplocalyx oil 67.54  1.16b 8.25  4.11b 4.46  0.61b 938.40  629.09b 5.06
(0.70)
130.74  3.95 0.77  0.15b 5.40  0.46b 83.54  39.85b 15.40
(1.19)
5% M.haplocalyx oil 74.76  2.14b 621.43  73.90b 6.10  0.24b 12293.80  1859.65b 206.90
(2.32)
135.77  1.86b 165.65  91.61b 7.03  0.24b 7127.66  505.97b 3313.00
(3.52)
a ERFlux is the enhancement ratio calculated as follows: ER Z Flux (with enhancer)/Flux (without enhancer); logER is natural logarithm
value of the corresponding ERFlux. Each value represents the mean  SD (n Z 5), except for ERFlux.
b P < 0.05, statistically significant difference between enhancers and control.
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Table 6 Percutaneous permeation parameters of GP through excised rat skin.
Enhancer GPa
Solubility (Mg/mL) Flux (mg/cm2/h) Tlag (h) Q24 (mg/cm
2) ERflux (logER)
b
Control 340.78  4.59 0.10  0.01 0.80  0.39 5.42  1.88
1% mint oil 339.28  0.56 0.11  0.06 1.05  0.74 5.85  2.49 1.10 (0.04)
3% mint oil 340.12  13.56 0.18  0.05 1.89  0.57 9.19  6.77 1.80 (0.26)
5% mint oil 343.15  7.73 80.96  51.08 6.55  0.64 8048.94  1183.64 809.60 (2.91)
P < 0.05, statistically significant difference between enhancers and control.
a Values expressed as mean  SD (n Z 5), except for ERFlux.
b ERFlux is the enhancement ratio calculated as follows: ERZ Flux (with enhancer)/Flux (without enhancer); logER is natural logarithm
value of the corresponding ERFlux.
Figure 3 Relationship between the logKo/w of model drugs
and the logERFlux of the corresponding drugs (OT, TMP, FA, PR,
and GP) using different concentrations of mint (M. haplocalyx)
oil as a penetration enhancer.
Percutaneous penetration enhancement effect of mint oil 117mint oil appeared to show higher efficiency for the pene-
tration of moderate hydrophilic drugs. Remarkably, the
logERflux of 1% mint oil did not change markedly with the
logKo/w of the model drugs due to its low penetration effect
on those model drugs.
Possible penetration enhancement mechanisms of
mint oil
Although the mechanism of drug diffusion across skin ap-
pears complex in many similar studies, their enhancementTable 7 Partition coefficients of model drugs treated with diff
Enhancer OT TMP FA
Ka PER Ka PER Ka
Control 0.020  0.004 e 0.047  0.006 e 0.092
1% mint oil 0.055  0.009 2.75 0.015  0.001 0.31 0.131
3% mint oil 0.043  0.011 2.16 0.016  0.012 0.34 0.167
5% mint oil 0.053  0.032 2.64 0.049  0.022 1.05 0.187
P < 0.05, statistically significant difference between enhancers and c
Note: K: partition coefficient; PER: penetration enhancement ratio,
(partition coefficient without essential oil treatment).
a K values are expressed as mean  SD (n Z 3).activities have been suggested as follows8: (1) change in
thermodynamic activity of drug molecules causing the
penetrants to readily permeate the skin; (2) increasing
partitioning of the drug molecules into the SC; (3) inter-
action with lipids or keratin of the SC resulting in disorga-
nization of the highly ordered structures thus enhancing
delivery of drug molecules across the SC.13 Certainly, other
potential mechanisms for explaining the activity probably
exist. Thus, the effect of mint oil on drug saturation solu-
bility, SC/vehicle partition coefficient of model drugs, and
secondary structure changes of SC were investigated in an
attempt to explain the penetration enhancement mecha-
nisms of mint oil.
The effect of mint oil on the saturation solubility of five
model drugs is summarized in Tables 4e6. The saturation
solubility of the four model drugs (OT, TMP, FA, and PR)
gradually increased as oil concentration increased, sug-
gesting that the thermodynamic activity of these model
drugs could be changed to some extent in the presence of
the essential oil.14,15 Mint oil did not significantly alter
(P > 0.05) saturation solubility of GP, indicating that the oil
had no obvious effect on the thermodynamic activity of GP.
Mint oil tended to increase saturation solubility of lipophilic
drugs due to its lipophilicity properties, but contributed
negligibly to that of hydrophilic drugs, which was the par-
tial reason why the skin permeability of these lipophilic
drugs was improved with incorporation of mint oil.
The results of SC/vehicle partition coefficient of the five
model drugs with and without different concentrations of
mint oil are listed in Table 7. Mint oil did not significantly
increase (P > 0.05) SC/vehicle partition coefficient of OT,
except for its 1% concentration, compared with the control.
Meanwhile, SC/vehicle coefficient of TMP actuallyerent concentrations of mint oil.
PR GP
PER Ka PER Ka PER
 0.022 e 0.052  0.016 e 0.072  0.017 e
 0.014 1.42 0.025  0.016 0.49 0.070  0.013 0.97
 0.008 1.81 0.124  0.010 2.39 0.113  0.010 1.56
 0.009 2.03 0.161  0.039 3.09 0.136  0.024 1.89
ontrol.
with PERZ (partition coefficient with essential oil treatment)/
Figure 4 FTIR spectra of rat stratum corneum after treatment with different agents for 12 hours.
118 J. Wang et al.decreased in the presence of mint oil. However, SC/vehicle
partition coefficients of FA, PR, and GP gradually increased
as oil concentration increased, and the variation trend was
similar to their permeation enhancement activity. This
implied that mint oil could readily increase the partition of
hydrophilic drugs into the SC, likely resulting in enhanced
skin permeability of hydrophilic drugs.
Tlag can reflect changes in the length of the permeation
path (h) and diffusion coefficient (D) according to Eq. (2) as
described above, and the diffusivity can be affected by
structural alteration of lipid and keratin in the SC by
penetration enhancers. As evident from Tables 4e6, Tlag
values of most examined drugs were gradually increased
with increasing oil concentration, indicating that mint oil
probably interacted with the SC lipids or keratin to change
its barrier properties. FTIR was thus employed to investi-
gate the biophysical changes of skin SC on account of its
advantages in obtaining information about the lipid and
protein conformation.
A representative spectrum of normal untreated skin SC
showed absorption peaks around 2850 and 2918 cm1 due to
symmetric and asymmetric CeH stretching vibration of lipidTable 8 Peak positions of lipids and amides in stratum corneum
Enhancer Peak positions of lipid (cm1)
Asymmetric CeH stretching Symmetric
Blank 2917.85 2849.82
Control 2918.10 2849.93
1% mint oil 2919.23 2850.34
3% mint oil 2918.95 2850.24
5% mint oil 2920.81 2850.78alkyl chains,16 eC]O peak of ester at 1740 cm1 region,11
and two strong amide absorption peaks in the range of
1500e1700 cm1, namely amide I (w1650 cm1) and amide
II (w1550 cm1).17,18 The shift to a higher frequency
occurred when CH2 groups along the alkyl chain of lipids
changed from trans to gauche conformation, and indicated
that the SC lipid was disturbed,13 and the change in the
amide I and amide II absorption peaks was observed, indi-
cating alterations in the keratin conformation under the
effect of penetration enhancers.9,19 In addition, fre-
quencies of fatty acid carbonyl stretching (eC]O peak of
ester) modes were sensitive to hydrogen bonding and pro-
vided information on head-group interactions in SC lipids.18
FTIR absorption spectra and peak positions of lipids and
amides in rat SC treated with different concentrations of
mint oil are illustrated in Fig. 4 and Table 8, respectively.
FTIR of rat SC treated with solvent showed no obvious shift
in wave number in comparison with the control, indicating
that PG: H2O (80:20, v/v) system was inefficient to perturb
SC lipid or keratin. After treatment with different con-
centrations of mint oil, the two CeH stretching vibration
peaks shifted to a higher frequency, and 5% mint oilafter treatment with various agents.
Peak positions of amide (cm1)
CeH stretching Amide I Amide II
1652.08 1538.89
1651.77 1538.56
1652.28 1538.89
1652.38 1539.06
1651.40 1538.46
Percutaneous penetration enhancement effect of mint oil 119resulted in a shift of approximately 3 cm1 in asymmetric
CeH stretching peak. Meanwhile, the wavelength move-
ments of amide I and amide II bands were narrow, indi-
cating mint oil changed SC barrier mainly by perturbing SC
lipids rather than affecting SC proteins. In addition, the
eC]O peak of fatty acid gradually disappeared as oil
concentration increased, suggesting that alteration in the
hydrogen bond of the polar regions of the lipid bilayers
occurred.
Conclusions
Results of this study appeared to show that mint (Mentha
haplocalyx Briq.) oil possessed lower cytotoxicity compared
with the standard and well-established penetration
enhancer Azone, and effectively facilitated the percuta-
neous permeation of five model drugs with different lip-
ophilicity in a concentration-dependent manner. The
relationship between the logKo/w of the model drugs and
their logERflux tended to be in parabolic curve, indicating
that mint oil probably exhibited higher efficiency on the
percutaneous penetration of moderate hydrophilic drugs in
Chinese herbal external preparations. Saturation solubility
and SC/vehicle partition coefficient studies revealed that
mint oil was prone to increase saturation solubility of
lipophilic drugs due to its lipophilicity properties and
improve the partition of hydrophilic drugs into skin stratum
corneum. FTIR studies exhibited that mint oil changed the
barrier function of the stratum corneum mainly by per-
turbing stratum corneum lipids.
In conclusion, mint oil at proper concentration appeared
to effectively facilitate percutaneous permeation of both
hydrophilic and lipophilic drugs in Chinese herbal external
preparations, and exhibited higher efficiency for the
percutaneous permeation of moderate hydrophilic drugs.
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